IPO Edge and the Palm Beach Hedge Fund Association hosted a fireside chat with GameSquare Holdings, Inc. (Nasdaq: GAME) to discuss the booming esports industry, the impact of the merger with FaZe as the biggest gaming worldwide brand, and more. The event...

IPO Edge and the Palm Beach Hedge Fund Association hosted a fireside chat with GameSquare Holdings, Inc. (Nasdaq: GAME) to discuss the booming esports industry, the impact of the merger with FaZe as the biggest gaming worldwide brand, and more. The event...

By Daniella Parra Sparrow Pharmaceuticals shared data on the combination of clofutriben (SPI-62), an HSD-1 inhibitor, and prednisolone for treating polymyalgia rheumatica (PMR). The company said that HSD-1 inhibition can reduce glucocorticoid side effects while maintaining treatment efficacy and combining...

By Equities First China is leading the world in clean energy investment. In 2022, China invested $546 billion in renewable energy sources like solar and wind, electric vehicles, and battery technologies. That accounted for nearly half of the entire world’s...

By Daniella Parra NANO-X IMAGING LTD (Nasdaq: NNOX) has integrated FDA-cleared AI solutions into its Second Opinions online consultation service, offered by its subsidiary, USARAD Holdings INC, the company said. This platform connects patients with specialists for additional diagnostic consultations,...

By Daniella Parra Lisata Therapeutics (Nasdaq: LSTA), said it has fully enrolled the pancreatic cancer cohort for the CENDIFOX trial. The company said it evaluates certepetide with FOLFIRINOX therapies in pancreatic, colon, and appendiceal cancers and the trial is being...

By Karen Roman Aktis Oncology said it appointed Dr. Ken Herrmann to the Board of Directors. Dr. Herrmann specializes in nuclear medicine and has over a decade of experience in clinical investigation, the company said. “Ken’s joining us on the...

By Karen Roman Vivani Medical, Inc. (Nasdaq: VANI) said the FDA allowed the beginning of a phase 1 for the clinical trial of NPM-119, its long-term mini-implant for type-2 diabetes treatment. Vivani is also advancing in the development of NPM-115...

By Daniella Parra Imperium Health and DecisionRx are teaming up to provide free Medication Therapy Optimization (MTO) to Medicare patients in Imperium’s Accountable Care Organizations (ACOs), the company said. This program aims to enhance patient outcomes and cut healthcare costs...

By Karen Roman The Duckhorn Portfolio, Inc. (NYSE: NAPA) reported net sales increased 1.4% year over year to reach $92.5 million in its Q3 2024 results. Adjusted EBITDA grew 5.3% to $37.7 million year over year and adjusted EBITDA margin...